Publication | Open Access
A novel thiol-saccharide mucolytic for the treatment of muco-obstructive lung diseases
31
Citations
31
References
2023
Year
MUC-031 is a potent and fast-acting mucolytic that decreases airway mucus plugging, lessens airway inflammation and improves survival in βENaC-Tg mice. These data provide rationale for human trials of MUC-031 in muco-obstructive lung diseases.
| Year | Citations | |
|---|---|---|
Page 1
Page 1